Bausch + Lomb Quarterly Income Statement
NYSE: BLCOHealth CareOphthalmic GoodsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Bausch + Lomb revenue and earnings
In the quarter ended Jun 30, 2026, Bausch + Lomb generated $1.39 billion in revenue, up 9.1% from the same quarter a year earlier. Bausch + Lomb reported a net loss of $14.0 million, compared with a loss of $62.0 million a year earlier. Operating margin was 6.0%.
Diluted earnings per share came in at -$0.04.
Summary generated from market data by MetaCap's automated system. Methodology
Bausch + Lomb income statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.39B | 1.24B | 1.41B | 1.28B | 1.28B | 1.14B | 1.28B | 1.20B | 1.22B | 1.10B | 1.17B | 1.01B |
| Revenue growth (YoY) | +9.08% | +9.41% | +9.77% | +7.11% | +5.10% | +3.46% | +9.12% | +18.77% | +17.49% | +18.05% | +17.77% | +6.90% |
| Research & Development | 114.00M | 101.00M | 94.00M | 95.00M | 96.00M | 86.00M | 93.00M | 84.00M | 84.00M | 82.00M | 80.00M | 82.00M |
| Selling, General & Admin | 588.00M | 544.00M | 564.00M | 528.00M | 579.00M | 563.00M | 532.00M | 511.00M | 535.00M | 504.00M | 483.00M | 418.00M |
| Operating Income | 83.00M | 33.00M | 112.00M | 95.00M | -11.00M | -83.00M | 87.00M | 43.00M | 26.00M | 6.00M | 49.00M | 40.00M |
| Interest Expense | 93.00M | 97.00M | 98.00M | 101.00M | 128.00M | 94.00M | 98.00M | 100.00M | 102.00M | 99.00M | 99.00M | 76.00M |
| Other Income (Expense) | — | — | — | — | — | — | — | — | — | -9.00M | -20.00M | -28.00M |
| Pretax Income | -11.00M | -64.00M | 13.00M | -3.00M | -147.00M | -180.00M | -10.00M | -58.00M | -76.00M | -90.00M | -57.00M | -35.00M |
| Income Tax | -1.00M | 6.00M | 71.00M | 22.00M | -89.00M | 31.00M | -8.00M | -66.00M | 72.00M | 73.00M | -6.00M | 45.00M |
| Net Income | -14.00M | -71.00M | -58.00M | -28.00M | -62.00M | -212.00M | -3.00M | 4.00M | -151.00M | -167.00M | -54.00M | -84.00M |
| Net Income growth (YoY) | — | — | — | -800.00% | — | — | — | — | — | — | — | — |
| EPS (Basic) | -0.04 | -0.20 | -0.16 | -0.08 | -0.18 | -0.60 | 0.00 | 0.01 | -0.43 | -0.48 | -0.15 | -0.24 |
| EPS (Diluted) | -0.04 | -0.20 | -0.16 | -0.08 | -0.18 | -0.60 | 0.00 | 0.01 | -0.43 | -0.48 | -0.15 | -0.24 |
| Shares Outstanding (Basic) | 357.10M | 355.20M | — | 354.20M | 353.70M | 352.80M | — | 351.90M | 351.80M | 351.10M | — | 350.80M |
| Shares Outstanding (Diluted) | 357.10M | 355.20M | — | 354.20M | 353.70M | 352.80M | — | 353.90M | 351.80M | 351.10M | — | 350.80M |
| EBITDA | 185.00M | 134.00M | 211.00M | 204.00M | 96.00M | 23.00M | 193.00M | 153.00M | 136.00M | 116.00M | 165.00M | 122.00M |
| Operating Margin | 5.95% | 2.65% | 7.97% | 7.42% | -86.00% | -7.30% | 6.80% | 3.60% | 2.14% | 55.00% | 4.18% | 3.97% |
| Net Margin | -100.00% | -5.71% | -4.13% | -2.19% | -4.85% | -18.65% | -23.00% | 33.00% | -12.42% | -15.20% | -4.60% | -8.34% |
This table shows 12 quarterly periods of Bausch + Lomb's income statement, from Q2 2026 back to Q3 2023, across 16 line items including revenue, research & development, selling, general & admin. Values in USD; B = billions, M = millions. Fiscal periods follow BLCO's reporting calendar. What is a income statement?